[Skip to Content]
[Skip to Content Landing]

Subclinical HypothyroidismA Review

Educational Objective
To learn about the underlying etiologies, clinical relevance, and management strategies of subclinical hypothyroidism.
1 Credit CME
Abstract

Importance  Subclinical hypothyroidism, defined as an elevated serum thyrotropin (often referred to as thyroid-stimulating hormone, or TSH) level with normal levels of free thyroxine (FT4) affects up to 10% of the adult population.

Observations  Subclinical hypothyroidism is most often caused by autoimmune (Hashimoto) thyroiditis. However, serum thyrotropin levels rise as people without thyroid disease age; serum thyrotropin concentrations may surpass the upper limit of the traditional reference range of 4 to 5 mU/L among elderly patients. This phenomenon has likely led to an overestimation of the true prevalence of subclinical hypothyroidism in persons older than 70 years. In patients who have circulating thyroid peroxidase antibodies, there is a greater risk of progression from subclinical to overt hypothyroidism. Subclinical hypothyroidism may be associated with an increased risk of heart failure, coronary artery disease events, and mortality from coronary heart disease. In addition, middle-aged patients with subclinical hypothyroidism may have cognitive impairment, nonspecific symptoms such as fatigue, and altered mood. In the absence of large randomized trials showing benefit from levothyroxine therapy, the rationale for treatment is based on the potential for decreasing the risk of adverse cardiovascular events and the possibility of preventing progression to overt hypothyroidism. However, levothyroxine therapy may be associated with iatrogenic thyrotoxicosis, especially in elderly patients, and there is no evidence that it is beneficial in persons aged 65 years or older.

Conclusions and Relevance  Subclinical hypothyroidism is common and most individuals can be observed without treatment. Treatment might be indicated for patients with subclinical hypothyroidism and serum thyrotropin levels of 10 mU/L or higher or for young and middle-aged individuals with subclinical hypothyroidism and symptoms consistent with mild hypothyroidism.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Corresponding Author: David S. Cooper, MD, Division of Endocrinology, Diabetes, and Metabolism, The Johns Hopkins University School of Medicine, 1830 E Monument St, Ste 333, Baltimore, MD 21287 (dscooper@jhmi.edu).

Author Contributions: Dr Cooper had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: All authors.

Acquisition, analysis, or interpretation of data: Cooper, Cappola.

Drafting of the manuscript: All authors.

Critical revision of the manuscript for important intellectual content: Cooper.

Supervision: All authors.

Conflict of Interest Disclosures: None reported.

Disclaimer: Dr Cappola is an associate editor of JAMA, but she was not involved in any of the decisions regarding review of the manuscript or its acceptance.

References
1.
Cooper  DS, Biondi  B.  Subclinical thyroid disease.  Lancet. 2012;379(9821):1142-1154. doi:10.1016/S0140-6736(11)60276-6PubMedGoogle ScholarCrossref
2.
Canaris  GJ, Manowitz  NR, Mayor  G, Ridgway  EC.  The Colorado thyroid disease prevalence study.  Arch Intern Med. 2000;160(4):526-534. doi:10.1001/archinte.160.4.526PubMedGoogle ScholarCrossref
3.
Hollowell  JG, Staehling  NW, Flanders  WD,  et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994).  J Clin Endocrinol Metab. 2002;87(2):489-499. doi:10.1210/jcem.87.2.8182PubMedGoogle ScholarCrossref
4.
Somwaru  LL, Rariy  CM, Arnold  AM, Cappola  AR.  The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study.  J Clin Endocrinol Metab. 2012;97(6):1962-1969. doi:10.1210/jc.2011-3047PubMedGoogle ScholarCrossref
5.
Surks  MI, Hollowell  JG.  Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population.  J Clin Endocrinol Metab. 2007;92(12):4575-4582. doi:10.1210/jc.2007-1499PubMedGoogle ScholarCrossref
6.
Bremner  AP, Feddema  P, Leedman  PJ,  et al.  Age-related changes in thyroid function.  J Clin Endocrinol Metab. 2012;97(5):1554-1562. doi:10.1210/jc.2011-3020PubMedGoogle ScholarCrossref
7.
Waring  AC, Arnold  AM, Newman  AB, Bùzková  P, Hirsch  C, Cappola  AR.  Longitudinal changes in thyroid function in the oldest old and survival.  J Clin Endocrinol Metab. 2012;97(11):3944-3950. doi:10.1210/jc.2012-2481PubMedGoogle ScholarCrossref
8.
Andersen  S, Pedersen  KM, Bruun  NH, Laurberg  P.  Narrow individual variations in serum T(4) and T(3) in normal subjects.  J Clin Endocrinol Metab. 2002;87(3):1068-1072. doi:10.1210/jcem.87.3.8165PubMedGoogle ScholarCrossref
9.
Hansen  PS, Brix  TH, Sørensen  TI, Kyvik  KO, Hegedüs  L.  Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins.  J Clin Endocrinol Metab. 2004;89(3):1181-1187. doi:10.1210/jc.2003-031641PubMedGoogle ScholarCrossref
10.
Peeters  RP.  Subclinical Hypothyroidism.  N Engl J Med. 2017;376(26):2556-2565. doi:10.1056/NEJMcp1611144PubMedGoogle ScholarCrossref
11.
Rodondi  N, den Elzen  WP, Bauer  DC,  et al; Thyroid Studies Collaboration.  Subclinical hypothyroidism and the risk of coronary heart disease and mortality.  JAMA. 2010;304(12):1365-1374. doi:10.1001/jama.2010.1361PubMedGoogle ScholarCrossref
12.
Blum  MR, Bauer  DC, Collet  TH,  et al; Thyroid Studies Collaboration.  Subclinical thyroid dysfunction and fracture risk.  JAMA. 2015;313(20):2055-2065. doi:10.1001/jama.2015.5161PubMedGoogle ScholarCrossref
13.
Alexander  EK, Pearce  EN, Brent  GA,  et al.  2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum.  Thyroid. 2017;27(3):315-389. doi:10.1089/thy.2016.0457PubMedGoogle ScholarCrossref
14.
Gussekloo  J, van Exel  E, de Craen  AJ, Meinders  AE, Frölich  M, Westendorp  RG.  Thyroid status, disability and cognitive function, and survival in old age.  JAMA. 2004;292(21):2591-2599. doi:10.1001/jama.292.21.2591PubMedGoogle ScholarCrossref
15.
Simonsick  EM, Newman  AB, Ferrucci  L,  et al; Health ABC Study.  Subclinical hypothyroidism and functional mobility in older adults.  Arch Intern Med. 2009;169(21):2011-2017. doi:10.1001/archinternmed.2009.392PubMedGoogle ScholarCrossref
16.
Pearce  SH, Razvi  S, Yadegarfar  ME,  et al.  Serum thyroid function, mortality and disability in advanced old age.  J Clin Endocrinol Metab. 2016;101(11):4385-4394. doi:10.1210/jc.2016-1935PubMedGoogle ScholarCrossref
17.
Tonacchera  M, Di Cosmo  C, De Marco  G,  et al.  Identification of TSH receptor mutations in three families with resistance to TSH.  Clin Endocrinol (Oxf). 2007;67(5):712-718. doi:10.1111/j.1365-2265.2007.02950.xPubMedGoogle ScholarCrossref
18.
Chikunguwo  S, Brethauer  S, Nirujogi  V,  et al.  Influence of obesity and surgical weight loss on thyroid hormone levels.  Surg Obes Relat Dis. 2007;3(6):631-635. doi:10.1016/j.soard.2007.07.011PubMedGoogle ScholarCrossref
19.
Kok  P, Roelfsema  F, Frölich  M, Meinders  AE, Pijl  H.  Spontaneous diurnal thyrotropin secretion is enhanced in proportion to circulating leptin in obese premenopausal women.  J Clin Endocrinol Metab. 2005;90(11):6185-6191. doi:10.1210/jc.2005-0003PubMedGoogle ScholarCrossref
20.
Santini  F, Marzullo  P, Rotondi  M,  et al.  Mechanisms in endocrinology crosstalk between thyroid gland and adipose tissue.  Eur J Endocrinol. 2014;171(4):R137-R152. doi:10.1530/EJE-14-0067PubMedGoogle ScholarCrossref
21.
Hamblin  PS, Dyer  SA, Mohr  VS,  et al.  Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness.  J Clin Endocrinol Metab. 1986;62(4):717-722. doi:10.1210/jcem-62-4-717PubMedGoogle ScholarCrossref
22.
Spencer  C, Eigen  A, Shen  D,  et al.  Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients.  Clin Chem. 1987;33(8):1391-1396.PubMedGoogle Scholar
23.
Lee  DY, Seok  J, Jeong  WJ, Ahn  SH.  Prediction of thyroid hormone supplementation after thyroid lobectomy.  J Surg Res. 2015;193(1):273-278. doi:10.1016/j.jss.2014.07.003PubMedGoogle ScholarCrossref
24.
Park  S, Jeon  MJ, Song  E,  et al.  Clinical features of early and late postoperative hypothyroidism after lobectomy.  J Clin Endocrinol Metab. 2017;102(4):1317-1324. doi:10.1210/jc.2016-3597PubMedGoogle ScholarCrossref
25.
Koulouri  O, Moran  C, Halsall  D, Chatterjee  K, Gurnell  M.  Pitfalls in the measurement and interpretation of thyroid function tests.  Best Pract Res Clin Endocrinol Metab. 2013;27(6):745-762. doi:10.1016/j.beem.2013.10.003PubMedGoogle ScholarCrossref
26.
Hattori  N, Ishihara  T, Yamagami  K, Shimatsu  A.  Macro TSH in patients with subclinical hypothyroidism.  Clin Endocrinol (Oxf). 2015;83(6):923-930. doi:10.1111/cen.12643PubMedGoogle ScholarCrossref
27.
Meyerovitch  J, Rotman-Pikielny  P, Sherf  M, Battat  E, Levy  Y, Surks  MI.  Serum thyrotropin measurements in the community.  Arch Intern Med. 2007;167(14):1533-1538. doi:10.1001/archinte.167.14.1533PubMedGoogle ScholarCrossref
28.
Biondi  B, Cooper  DS.  The clinical significance of subclinical thyroid dysfunction.  Endocr Rev. 2008;29(1):76-131. doi:10.1210/er.2006-0043PubMedGoogle ScholarCrossref
29.
Díez  JJ, Iglesias  P.  Spontaneous subclinical hypothyroidism in patients older than 55 years.  J Clin Endocrinol Metab. 2004;89(10):4890-4897. doi:10.1210/jc.2003-032061PubMedGoogle ScholarCrossref
30.
Vanderpump  MP, Tunbridge  WM, French  JM,  et al.  The incidence of thyroid disorders in the community.  Clin Endocrinol (Oxf). 1995;43(1):55-68. doi:10.1111/j.1365-2265.1995.tb01894.xPubMedGoogle ScholarCrossref
31.
Díez  JJ, Iglesias  P, Burman  KD.  Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism.  J Clin Endocrinol Metab. 2005;90(7):4124-4127. doi:10.1210/jc.2005-0375PubMedGoogle ScholarCrossref
32.
Li  Y, Teng  D, Shan  Z,  et al.  Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes.  J Clin Endocrinol Metab. 2008;93(5):1751-1757. doi:10.1210/jc.2007-2368PubMedGoogle ScholarCrossref
33.
Walsh  JP, Bremner  AP, Feddema  P, Leedman  PJ, Brown  SJ, O’Leary  P.  Thyrotropin and thyroid antibodies as predictors of hypothyroidism.  J Clin Endocrinol Metab. 2010;95(3):1095-1104. doi:10.1210/jc.2009-1977PubMedGoogle ScholarCrossref
34.
Canaris  GJ, Steiner  JF, Ridgway  EC.  Do traditional symptoms of hypothyroidism correlate with biochemical disease?  J Gen Intern Med. 1997;12(9):544-550. doi:10.1046/j.1525-1497.1997.07109.xPubMedGoogle ScholarCrossref
35.
Klaver  EI, van Loon  HC, Stienstra  R,  et al.  Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.  Thyroid. 2013;23(9):1066-1073. doi:10.1089/thy.2013.0017PubMedGoogle ScholarCrossref
36.
Correia  N, Mullally  S, Cooke  G,  et al.  Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism.  J Clin Endocrinol Metab. 2009;94(10):3789-3797. doi:10.1210/jc.2008-2702PubMedGoogle ScholarCrossref
37.
Blum  MR, Wijsman  LW, Virgini  VS,  et al; PROSPER study group.  Subclinical thyroid dysfunction and depressive symptoms among the elderly.  Neuroendocrinology. 2016;103(3-4):291-299. doi:10.1159/000437387PubMedGoogle ScholarCrossref
38.
Kim  JS, Zhang  Y, Chang  Y,  et al.  Subclinical hypothyroidism and incident depression in young and middle-age adults.  J Clin Endocrinol Metab. 2018;103(5):1827-1833. doi:10.1210/jc.2017-01247PubMedGoogle ScholarCrossref
39.
Carlé  A, Pedersen  IB, Knudsen  N,  et al.  Hypothyroid symptoms fail to predict thyroid insufficiency in old people.  Am J Med. 2016;129(10):1082-1092. doi:10.1016/j.amjmed.2016.06.013PubMedGoogle ScholarCrossref
40.
Stott  DJ, Rodondi  N, Kearney  PM,  et al; TRUST Study Group.  Thyroid hormone therapy for older adults with subclinical hypothyroidism.  N Engl J Med. 2017;376(26):2534-2544. doi:10.1056/NEJMoa1603825PubMedGoogle ScholarCrossref
41.
Biondi  B, Palmieri  EA, Lombardi  G, Fazio  S.  Effects of subclinical thyroid dysfunction on the heart.  Ann Intern Med. 2002;137(11):904-914. doi:10.7326/0003-4819-137-11-200212030-00011PubMedGoogle ScholarCrossref
42.
Chen  X, Zhang  N, Cai  Y, Shi  J.  Evaluation of left ventricular diastolic function using tissue Doppler echocardiography and conventional doppler echocardiography in patients with subclinical hypothyroidism aged <60 years.  J Cardiol. 2013;61(1):8-15. doi:10.1016/j.jjcc.2012.08.017PubMedGoogle ScholarCrossref
43.
Owen  PJ, Sabit  R, Lazarus  JH.  Thyroid disease and vascular function.  Thyroid. 2007;17(6):519-524. doi:10.1089/thy.2007.0051PubMedGoogle ScholarCrossref
44.
Stone  NJ, Robinson  JG, Lichtenstein  AH,  et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults.  Circulation. 2014;129(25)(suppl 2):S1-S45. doi:10.1161/01.cir.0000437738.63853.7aPubMedGoogle ScholarCrossref
45.
Ebrahimpour  A, Vaghari-Tabari  M, Qujeq  D, Moein  S, Moazezi  Z.  Direct correlation between serum homocysteine level and insulin resistance index in patients with subclinical hypothyroidism.  Diabetes Metab Syndr. 2018;12(6):863-867. doi:10.1016/j.dsx.2018.05.002PubMedGoogle ScholarCrossref
46.
Liu  XL, He  S, Zhang  SF,  et al.  Alteration of lipid profile in subclinical hypothyroidism.  Med Sci Monit. 2014;20:1432-1441. doi:10.12659/MSM.891163PubMedGoogle ScholarCrossref
47.
Mantovani  A, Nascimbeni  F, Lonardo  A,  et al.  Association between primary hypothyroidism and nonalcoholic fatty liver disease.  Thyroid. 2018;28(10):1270-1284. doi:10.1089/thy.2018.0257PubMedGoogle ScholarCrossref
48.
Gao  N, Zhang  W, Zhang  YZ, Yang  Q, Chen  SH.  Carotid intima-media thickness in patients with subclinical hypothyroidism: a meta-analysis.  Atherosclerosis. 2013;227(1):18-25. doi:10.1016/j.atherosclerosis.2012.10.070PubMedGoogle ScholarCrossref
49.
Aziz  M, Kandimalla  Y, Machavarapu  A,  et al.  Effect of thyroxin treatment on carotid intima-media thickness (CIMT) reduction in patients with subclinical hypothyroidism (SCH): a meta-analysis of clinical trials.  J Atheroscler Thromb. 2017;24(7):643-659. doi:10.5551/jat.39917PubMedGoogle ScholarCrossref
50.
Gencer  B, Collet  TH, Virgini  V,  et al; Thyroid Studies Collaboration.  Subclinical thyroid dysfunction and the risk of heart failure events.  Circulation. 2012;126(9):1040-1049. doi:10.1161/CIRCULATIONAHA.112.096024PubMedGoogle ScholarCrossref
51.
Chaker  L, Baumgartner  C, den Elzen  WP,  et al; Thyroid Studies Collaboration.  Subclinical hypothyroidism and the risk of stroke events and fatal stroke.  J Clin Endocrinol Metab. 2015;100(6):2181-2191. doi:10.1210/jc.2015-1438PubMedGoogle ScholarCrossref
52.
Baumgartner  C, da Costa  BR, Collet  TH,  et al; Thyroid Studies Collaboration.  Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation.  Circulation. 2017;136(22):2100-2116. doi:10.1161/CIRCULATIONAHA.117.028753PubMedGoogle ScholarCrossref
53.
Collet  TH, Bauer  DC, Cappola  AR,  et al; Thyroid Studies Collaboration.  Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease.  J Clin Endocrinol Metab. 2014;99(9):3353-3362. doi:10.1210/jc.2014-1250PubMedGoogle ScholarCrossref
54.
Hyland  KA, Arnold  AM, Lee  JS, Cappola  AR.  Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study.  J Clin Endocrinol Metab. 2013;98(2):533-540. doi:10.1210/jc.2012-2180PubMedGoogle ScholarCrossref
55.
Pasqualetti  G, Pagano  G, Rengo  G, Ferrara  N, Monzani  F.  Subclinical hypothyroidism and cognitive impairment.  J Clin Endocrinol Metab. 2015;100(11):4240-4248. doi:10.1210/jc.2015-2046PubMedGoogle ScholarCrossref
56.
Akintola  AA, Jansen  SW, van Bodegom  D,  et al.  Subclinical hypothyroidism and cognitive function in people over 60 years.  Front Aging Neurosci. 2015;7:150. doi:10.3389/fnagi.2015.00150PubMedGoogle Scholar
57.
Rieben  C, Segna  D, da Costa  BR,  et al.  Subclinical thyroid dysfunction and the risk of cognitive decline.  J Clin Endocrinol Metab. 2016;101(12):4945-4954. doi:10.1210/jc.2016-2129PubMedGoogle ScholarCrossref
58.
Meuwese  CL, van Diepen  M, Cappola  AR,  et al; Thyroid Studies Collaboration.  Low thyroid function is not associated with an accelerated deterioration in renal function.  Nephrol Dial Transplant. 2019;34(4):650-659. doi:10.1093/ndt/gfy071PubMedGoogle ScholarCrossref
59.
Rhee  CM, Kim  S, Gillen  DL,  et al.  Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients.  J Clin Endocrinol Metab. 2015;100(4):1386-1395. doi:10.1210/jc.2014-4311PubMedGoogle ScholarCrossref
60.
Segna  D, Bauer  DC, Feller  M,  et al; Thyroid Studies Collaboration.  Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts.  J Intern Med. 2018;283(1):56-72. doi:10.1111/joim.12688PubMedGoogle ScholarCrossref
61.
Virgini  VS, Wijsman  LW, Rodondi  N,  et al; PROSPER Study Group.  Subclinical thyroid dysfunction and functional capacity among elderly.  Thyroid. 2014;24(2):208-214. doi:10.1089/thy.2013.0071PubMedGoogle ScholarCrossref
62.
Rao  M, Zeng  Z, Zhao  S, Tang  L.  Effect of levothyroxine supplementation on pregnancy outcomes in women with subclinical hypothyroidism and thyroid autoimmuneity undergoing in vitro fertilization/intracytoplasmic sperm injection.  Reprod Biol Endocrinol. 2018;16(1):92. doi:10.1186/s12958-018-0410-6PubMedGoogle ScholarCrossref
63.
Feller  M, Snel  M, Moutzouri  E,  et al.  Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism.  JAMA. 2018;320(13):1349-1359. doi:10.1001/jama.2018.13770PubMedGoogle ScholarCrossref
64.
Blum  MR, Gencer  B, Adam  L,  et al.  Impact of thyroid hormone therapy on atherosclerosis in the elderly with subclinical hypothyroidism: a randomized trial.  J Clin Endocrinol Metab. 2018;103(8):2988-2997. doi:10.1210/jc.2018-00279PubMedGoogle ScholarCrossref
65.
Rugge  JB, Bougatsos  C, Chou  R.  Screening and treatment of thyroid dysfunction.  Ann Intern Med. 2015;162(1):35-45. doi:10.7326/M14-1456PubMedGoogle ScholarCrossref
66.
Razvi  S, Weaver  JU, Butler  TJ, Pearce  SH.  Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality.  Arch Intern Med. 2012;172(10):811-817. doi:10.1001/archinternmed.2012.1159PubMedGoogle ScholarCrossref
67.
Andersen  MN, Olsen  AM, Madsen  JC,  et al.  Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality.  PLoS One. 2015;10(6):e0129793. doi:10.1371/journal.pone.0129793PubMedGoogle ScholarCrossref
68.
Garber  JR, Cobin  RH, Gharib  H,  et al; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults.  Clinical practice guidelines for hypothyroidism in adults.  Thyroid. 2012;22(12):1200-1235. doi:10.1089/thy.2012.0205PubMedGoogle ScholarCrossref
69.
Jonklaas  J, Bianco  AC, Bauer  AJ,  et al; American Thyroid Association Task Force on Thyroid Hormone Replacement.  Guidelines for the treatment of hypothyroidism.  Thyroid. 2014;24(12):1670-1751. doi:10.1089/thy.2014.0028PubMedGoogle ScholarCrossref
70.
Pearce  SH, Brabant  G, Duntas  LH,  et al.  2013 ETA Guideline: management of subclinical hypothyroidism.  Eur Thyroid J. 2013;2(4):215-228. doi:10.1159/000356507PubMedGoogle ScholarCrossref
71.
Brenta  G, Vaisman  M, Sgarbi  JA,  et al; Task Force on Hypothyroidism of the Latin American Thyroid Society (LATS).  Clinical practice guidelines for the management of hypothyroidism.  Arq Bras Endocrinol Metabol. 2013;57(4):265-291. doi:10.1590/S0004-27302013000400003PubMedGoogle ScholarCrossref
72.
Somwaru  LL, Arnold  AM, Joshi  N, Fried  LP, Cappola  AR.  High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over.  J Clin Endocrinol Metab. 2009;94(4):1342-1345. doi:10.1210/jc.2008-1696PubMedGoogle ScholarCrossref
73.
Taylor  PN, Iqbal  A, Minassian  C,  et al.  Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks.  JAMA Intern Med. 2014;174(1):32-39. doi:10.1001/jamainternmed.2013.11312PubMedGoogle ScholarCrossref
74.
Flynn  RW, Bonellie  SR, Jung  RT, MacDonald  TM, Morris  AD, Leese  GP.  Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy.  J Clin Endocrinol Metab. 2010;95(1):186-193. doi:10.1210/jc.2009-1625PubMedGoogle ScholarCrossref
75.
Okosieme  O, Gilbert  J, Abraham  P,  et al.  Management of primary hypothyroidism.  Clin Endocrinol (Oxf). 2016;84(6):799-808. doi:10.1111/cen.12824PubMedGoogle ScholarCrossref
76.
Walsh  JP, Ward  LC, Burke  V,  et al.  Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life.  J Clin Endocrinol Metab. 2006;91(7):2624-2630. doi:10.1210/jc.2006-0099PubMedGoogle ScholarCrossref
77.
Samuels  MH, Kolobova  I, Niederhausen  M, Janowsky  JS, Schuff  KG.  Effects of altering levothyroxine (L-T4) doses on quality of life, mood, and cognition in L-T4 treated subjects.  J Clin Endocrinol Metab. 2018;103(5):1997-2008. doi:10.1210/jc.2017-02668PubMedGoogle ScholarCrossref
78.
Samuels  MH, Kolobova  I, Niederhausen  M, Purnell  JQ, Schuff  KG.  Effects of altering levothyroxine dose on energy expenditure and body composition in subjects treated with LT4.  J Clin Endocrinol Metab. 2018;103(11):4163-4175. doi:10.1210/jc.2018-01203PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right

Name Your Search

Save Search
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Topics
State Requirements